Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells

Abstract Background and objectives Dexmedetomidine (DEX) has demonstrated the preconditioning effect and shown protective effects against organize injury. In this study, using A549 (human alveolar epithelial cell) cell lines, we investigated whether DEX preconditioning protected against acute lung injury (ALI) in vitro. Methods A549 were randomly divided into four groups (n = 5): control group, DEX group, lipopolysaccharides (LPS) group, and D-LPS (DEX + LPS) group. Phosphate buffer saline (PBS) or DEX were administered. After 2 h preconditioning, the medium was refreshed and the cells were challenged with LPS for 24 h on the LPS and D-LPS group. Then the malondialdehyde (MDA), superoxide dismutase (SOD), Bcl-2, Bax, caspase-3 and the cytochrome c in the A549 were tested. The apoptosis was also evaluated in the cells. Results Compare with LPS group, DEX preconditioning reduced the apoptosis (26.43% ± 1.05% vs. 33.58% ± 1.16%, p < 0.05) in the A549, which is correlated with decreased MDA (12.84 ± 1.05 vs. 19.16 ± 1.89 nmoL.mg-1 protein, p < 0.05) and increased SOD activity (30.28 ± 2.38 vs. 20.86 ± 2.19 U.mg-1 protein, p < 0.05). DEX preconditioning also increased the Bcl-2 level (0.53 ± 0.03 vs. 0.32 ± 0.04, p < 0.05) and decreased the level of Bax (0.49 ± 0.04 vs. 0.65 ± 0.04, p < 0.05), caspase-3 (0.54 ± 0.04 vs. 0.76 ± 0.04, p < 0.05) and cytochrome c. Conclusion DEX preconditioning has a protective effect against ALI in vitro. The potential mechanisms involved are the inhibition of cell death and improvement of antioxidation.

Saved in:
Bibliographic Details
Main Authors: Zhang,Lei, Zhou,Xian-Jin, Zhan,Li-Ying, Wu,Xiao-Jing, Li,Wen-Lan, Zhao,Bo, Meng,Qing-Tao, Xia,Zhong-Yuan
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Anestesiologia 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942017000600600
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-70942017000600600
record_format ojs
spelling oai:scielo:S0034-709420170006006002017-11-29Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cellsZhang,LeiZhou,Xian-JinZhan,Li-YingWu,Xiao-JingLi,Wen-LanZhao,BoMeng,Qing-TaoXia,Zhong-Yuan Dexmedetomidine Lipopolysaccharides Preconditioning Acute lung injury Alveolar epithelial cell Abstract Background and objectives Dexmedetomidine (DEX) has demonstrated the preconditioning effect and shown protective effects against organize injury. In this study, using A549 (human alveolar epithelial cell) cell lines, we investigated whether DEX preconditioning protected against acute lung injury (ALI) in vitro. Methods A549 were randomly divided into four groups (n = 5): control group, DEX group, lipopolysaccharides (LPS) group, and D-LPS (DEX + LPS) group. Phosphate buffer saline (PBS) or DEX were administered. After 2 h preconditioning, the medium was refreshed and the cells were challenged with LPS for 24 h on the LPS and D-LPS group. Then the malondialdehyde (MDA), superoxide dismutase (SOD), Bcl-2, Bax, caspase-3 and the cytochrome c in the A549 were tested. The apoptosis was also evaluated in the cells. Results Compare with LPS group, DEX preconditioning reduced the apoptosis (26.43% ± 1.05% vs. 33.58% ± 1.16%, p < 0.05) in the A549, which is correlated with decreased MDA (12.84 ± 1.05 vs. 19.16 ± 1.89 nmoL.mg-1 protein, p < 0.05) and increased SOD activity (30.28 ± 2.38 vs. 20.86 ± 2.19 U.mg-1 protein, p < 0.05). DEX preconditioning also increased the Bcl-2 level (0.53 ± 0.03 vs. 0.32 ± 0.04, p < 0.05) and decreased the level of Bax (0.49 ± 0.04 vs. 0.65 ± 0.04, p < 0.05), caspase-3 (0.54 ± 0.04 vs. 0.76 ± 0.04, p < 0.05) and cytochrome c. Conclusion DEX preconditioning has a protective effect against ALI in vitro. The potential mechanisms involved are the inhibition of cell death and improvement of antioxidation.info:eu-repo/semantics/openAccessSociedade Brasileira de AnestesiologiaRevista Brasileira de Anestesiologia v.67 n.6 20172017-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942017000600600en10.1016/j.bjane.2017.02.002
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Zhang,Lei
Zhou,Xian-Jin
Zhan,Li-Ying
Wu,Xiao-Jing
Li,Wen-Lan
Zhao,Bo
Meng,Qing-Tao
Xia,Zhong-Yuan
spellingShingle Zhang,Lei
Zhou,Xian-Jin
Zhan,Li-Ying
Wu,Xiao-Jing
Li,Wen-Lan
Zhao,Bo
Meng,Qing-Tao
Xia,Zhong-Yuan
Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells
author_facet Zhang,Lei
Zhou,Xian-Jin
Zhan,Li-Ying
Wu,Xiao-Jing
Li,Wen-Lan
Zhao,Bo
Meng,Qing-Tao
Xia,Zhong-Yuan
author_sort Zhang,Lei
title Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells
title_short Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells
title_full Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells
title_fullStr Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells
title_full_unstemmed Dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells
title_sort dexmedetomidine preconditioning protects against lipopolysaccharides-induced injury in the human alveolar epithelial cells
description Abstract Background and objectives Dexmedetomidine (DEX) has demonstrated the preconditioning effect and shown protective effects against organize injury. In this study, using A549 (human alveolar epithelial cell) cell lines, we investigated whether DEX preconditioning protected against acute lung injury (ALI) in vitro. Methods A549 were randomly divided into four groups (n = 5): control group, DEX group, lipopolysaccharides (LPS) group, and D-LPS (DEX + LPS) group. Phosphate buffer saline (PBS) or DEX were administered. After 2 h preconditioning, the medium was refreshed and the cells were challenged with LPS for 24 h on the LPS and D-LPS group. Then the malondialdehyde (MDA), superoxide dismutase (SOD), Bcl-2, Bax, caspase-3 and the cytochrome c in the A549 were tested. The apoptosis was also evaluated in the cells. Results Compare with LPS group, DEX preconditioning reduced the apoptosis (26.43% ± 1.05% vs. 33.58% ± 1.16%, p < 0.05) in the A549, which is correlated with decreased MDA (12.84 ± 1.05 vs. 19.16 ± 1.89 nmoL.mg-1 protein, p < 0.05) and increased SOD activity (30.28 ± 2.38 vs. 20.86 ± 2.19 U.mg-1 protein, p < 0.05). DEX preconditioning also increased the Bcl-2 level (0.53 ± 0.03 vs. 0.32 ± 0.04, p < 0.05) and decreased the level of Bax (0.49 ± 0.04 vs. 0.65 ± 0.04, p < 0.05), caspase-3 (0.54 ± 0.04 vs. 0.76 ± 0.04, p < 0.05) and cytochrome c. Conclusion DEX preconditioning has a protective effect against ALI in vitro. The potential mechanisms involved are the inhibition of cell death and improvement of antioxidation.
publisher Sociedade Brasileira de Anestesiologia
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942017000600600
work_keys_str_mv AT zhanglei dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
AT zhouxianjin dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
AT zhanliying dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
AT wuxiaojing dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
AT liwenlan dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
AT zhaobo dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
AT mengqingtao dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
AT xiazhongyuan dexmedetomidinepreconditioningprotectsagainstlipopolysaccharidesinducedinjuryinthehumanalveolarepithelialcells
_version_ 1756376353289011200